Dr Jacob Scott received his medical degree from Case Western Reserve University School of Medicine and his doctor of philosophy in mathematics at the University of Oxford, St Anne’s College. He completed residency training and post-doctoral fellowship at H. Lee Moffit Cancer Center in Tampa, Florida. He studies mathematical modeling of how tumors evolve when treated with radiation. Dr Scott collaborates with Professor Trevor Graham at Barts Cancer Institute, Queen Mary University of London on mechanisms of carcinogenesis and cancer evolution. He is working with Dr Andrea Sottoriva of the Institute of Cancer Research, London on predicting cancer evolution and therapeutic sensitivities.
Dr Scott will be attending the International Society for Evolution, Ecology and Cancer Conference in July 2019 at the Wellcome Genome Campus, Hinxton, UK.
Dr Suneel Apte earned his doctor of philosophy in clinical medicine at the University of Oxford and trained as a post-doctoral fellow at Harvard Medical School. Dr Apte is an expert in extracellular matrix, proteases and their role in human diseases. His laboratory performs fundamental research to understand congenital birth defects, connective tissue disorders such as Marfan syndrome and acquired disorders such as aortic aneurysms, osteoarthritis, fibrosis and glaucoma. Dr Apte is a member of Oxford University’s Kennedy Institute of Rheumatology Scientific Advisory Board. He collaborates on matrix-degrading proteases with Professor David Lane’s group in the Centre for Haematology at Imperial College London. Dr Apte published recently with Dr Yalda Jamshidi at St. George’s University of London on genetics of cardiac conduction.
Dr Apte plans to visit London in autumn of 2019 to discuss his work.
Dr Christine O’Connor earned her doctorate from the University of Virginia in microbiology and completed post-doctoral fellowship training at Princeton University. Dr O’Connor studies latency, reactivation and viral pathogenesis of human cytomegalovirus. She holds a Burroughs Wellcome Collaborative Travel Research Grant that supports her work aimed at understanding epigenetic regulation during HCMV latency with Dr Peter DiMaggio at Imperial College London. Dr O’Connor also collaborates with Professor John Sinclair of the University of Cambridge studying the function of HCMV-encoded proteins during latency and reactivation. She is also working with Dr Matt Reeves of the University College London on HCMV latency and reactivation in the transplant setting.
Dr O’Connor will be visiting London in February, May and June of 2019.